Horvat Rebecca T
Department of Pathology and Laboratory Medicine, University of Kansas Medical Center, Kansas City, Kansas, USA
Clin Vaccine Immunol. 2015 Aug;22(8):845-9. doi: 10.1128/CVI.00199-15. Epub 2015 May 27.
Tuberculosis (TB) is an ancient disease that has infected humans for thousands of years. However, despite diagnostic tests that detect the disease and effective therapy, there are still millions of people worldwide who are infected with TB. The first TB test used to detect infected patients was a skin test that identifies individuals actively infected with TB. This test used a mix of proteins from culture filtrates of the bacteria Mycobacterium tuberculosis. Recently, two new diagnostic tests have been introduced; these two new tests can detect TB infection in patients by challenging peripheral blood cells with specific TB proteins. These assays measure the cellular immune response to these proteins. This minireview evaluates the new assays and compares them to the use of the TB skin test. The use of these new assays may have some advantages in detecting individuals with active tuberculosis. However, there is still a role for the use of the skin test, especially in young patients.
结核病是一种古老的疾病,已经感染人类数千年。然而,尽管有检测该疾病的诊断测试和有效的治疗方法,但全球仍有数百万人感染结核病。用于检测感染患者的首个结核病测试是一种皮肤测试,可识别出活跃感染结核病的个体。该测试使用了结核分枝杆菌培养滤液中的蛋白质混合物。最近,引入了两种新的诊断测试;这两种新测试可以通过用特定的结核蛋白刺激外周血细胞来检测患者的结核感染。这些检测方法测量对这些蛋白质的细胞免疫反应。本综述评估了这些新检测方法,并将它们与结核皮肤测试的使用进行了比较。使用这些新检测方法在检测活动性结核病患者方面可能具有一些优势。然而,皮肤测试仍然有其用途,特别是在年轻患者中。